Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Eur Rev Med Pharmacol Sci ; 28(5): 1998-2004, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-38497882

RESUMO

OBJECTIVE: In recent years, an overwhelming association between Pediatric Type 1 Diabetes Mellitus (T1DM) and autoimmune diseases has been largely reported. The current study was designed to determine a possible association between autoimmune thyroiditis (AIT), celiac disease (CD) - associated autoantibodies, and Parvovirus B19 infection among pediatric T1DM cases in the southwestern region of Saudi Arabia. PATIENTS AND METHODS: Blood samples from age groups 1-18 years attending the Diabetic Clinic were collected over a period of 12 months. Serum anti-thyroid peroxidase (TPO), anti-thyroglobulin (TG), anti-tissue transglutaminase immunoglobulin A (TG-IgA), endomysial IgA (EMA-IgA), Parvovirus B19-IgG and IgM antibodies were detected by standard methods. RESULTS: The results showed the prevalence of autoantibodies against thyroid and CD among pediatric T1DM patients to be 44 (25%) and 25 (14.4%), respectively. The prevalence of antibodies against B19 was 70 (40%). Further determination of the prevalence of Parvovirus B19-IgG antibodies and thyroid antibodies among T1DM pediatric patients revealed that there was a significant association between them with a p<0.0491. CONCLUSIONS: The prevalence of autoantibodies against the thyroid was higher among the seropositive Parvovirus B19 children with T1DM. A positive association between the prevalence of autoantibodies against thyroid disease and the increase in the duration of diabetes was also noted. Hence, periodic screening of T1DM patients for B19 antibodies and autoantibodies for thyroid is crucial.


Assuntos
Doença Celíaca , Diabetes Mellitus Tipo 1 , Parvovirus B19 Humano , Humanos , Criança , Lactente , Pré-Escolar , Adolescente , Glândula Tireoide , Autoanticorpos , Anticorpos Antivirais , Imunoglobulina G , Doença Celíaca/epidemiologia , Imunoglobulina A
2.
S Afr Med J ; 107(10): 843-846, 2017 09 22.
Artigo em Inglês | MEDLINE | ID: mdl-29022526

RESUMO

BACKGROUND: Retinal cytomegalovirus (CMV) infection is a common opportunistic infection and remains a significant contributor to visual loss in patients with AIDS. We highlight the poor outcomes of CMV retinitis in three HIV-infected patients who were initiated on antiretroviral therapy (ART). We conducted a retrospective chart review of advanced stage HIV-infected patients with known CMV retinitis.Case 1. A 37-year-old man, with a CD4+ cell count of 35 cells/µL, presented for ART initiation with a 5-month history of visual loss in his left eye. Fundoscopy showed left eye CMV retinitis and right eye HIV retinopathy. ART and 5 months of weekly intravitreal ganciclovir injections (left eye) were commenced. Six-month outcomes included virological suppression, and visual acuity in the right eye of 6/6 and in the left eye of 3/60.Case 2. A 31-year-old woman, with a CD4+ cell count of 39 cells/µL and on tuberculosis therapy, presented for ART initiation. She presented with a 2-month history of decreased visual acuity. Fundoscopy showed bilateral CMV retinitis, which was more pronounced in the left eye. ART and 8 months of intravitreal ganciclovir injections were commenced. Six-month outcomes included virological suppression and visual acuity in the right eye of 6/9, and in the left eye of 6/24.Case 3. A 29-year-old woman, with a CD4+ cell count of 24 cells/µL, who was on tuberculosis therapy and ART, complained of blurred vision at her 2-month ART follow-up visit. Fundoscopy showed bilateral retinal detachment secondary to CMV retinitis. While silicone oil tamponade and subsequent retinectomy successfully repaired the right eye, extensive damage rendered the left eye irreparable. Six-month outcomes included virological suppression, with 6/120 visual acuity in the right eye and complete blindness in the left eye. CONCLUSION: CMV retinitis causes debilitating, permanent sequelae, which is preventable by ART initiation at higher CD4+ cell counts. Despite achieving virological suppression, vision could not be completely restored in these patients, irrespective of the severity of CMV retinitis.


Assuntos
Infecções Oportunistas Relacionadas com a AIDS/complicações , Retinite por Citomegalovirus/complicações , Infecções por HIV/complicações , Infecções Oportunistas Relacionadas com a AIDS/tratamento farmacológico , Adulto , Fármacos Anti-HIV/uso terapêutico , Antivirais/uso terapêutico , Retinite por Citomegalovirus/tratamento farmacológico , Feminino , Ganciclovir/uso terapêutico , Infecções por HIV/tratamento farmacológico , Humanos , Masculino , Estudos Retrospectivos , África do Sul , Transtornos da Visão/etiologia
3.
Indian J Med Microbiol ; 29(2): 136-40, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21654107

RESUMO

PURPOSE: To compare the performance of two indirect enzyme-linked immunosorbent assays (ELISA) detecting Helicobacter pylori (HP)-specific IgG antibodies in serum and saliva with endoscopic observations and histologic findings of biopsies from dyspeptic patients, in an area of high HP prevalence. MATERIALS AND METHODS: Sera, saliva and antral biopsies were obtained from 55 dyspeptic patients. IgG antibodies against HP were assayed in sera and saliva utilizing two indirect ELISAs. Biopsies were processed according to standard procedures in order to detect histological changes and the presence or absence of Helicobacter pylori. Laboratory data thus obtained were compared and statistically analyzed. RESULTS: Forty-two (76.36%) biopsies were positive for HP. The organisms were detected in 4 of 16 (25%) cases with normal endoscopic findings, in all 16 cases of gastritis and in 22 of the 23 (95.6%) cases of duodenal ulcers (DU). Serum and saliva HP-specific IgG antibodies were detected in 4 normal cases with positive biopsies, in 12 and 14 cases of gastritis, respectively, and in all 22 (100%) biopsy positive cases of DU. The sensitivities of the serum and saliva tests were 90.5% and 95%, respectively, while the specificities were 84.5% and 70%, respectively. CONCLUSION: Due to their high sensitivity and specificity in diagnosing HP-associated DU and gastritis, serum and saliva antibody testing seems to offer a valuable alternative to invasive procedures especially in areas of high HP prevalence such as ours; saliva antibody testing is simple and practical especially in children and in difficult patients who resent venipuncture.


Assuntos
Anticorpos Antibacterianos/análise , Anticorpos Antibacterianos/sangue , Técnicas de Laboratório Clínico/métodos , Infecções por Helicobacter/diagnóstico , Helicobacter pylori/imunologia , Saliva/imunologia , Soro/imunologia , Adulto , Biópsia , Dispepsia/microbiologia , Dispepsia/patologia , Feminino , Infecções por Helicobacter/microbiologia , Infecções por Helicobacter/patologia , Helicobacter pylori/isolamento & purificação , Histocitoquímica , Humanos , Técnicas Imunoenzimáticas/métodos , Imunoglobulina G/análise , Imunoglobulina G/sangue , Masculino , Antro Pilórico/patologia , Sensibilidade e Especificidade
4.
Artigo em Inglês | AIM (África) | ID: biblio-1270483

RESUMO

Objective There has been considerable debate about the extent to which social cognitive models of health behaviour apply in developing countries. The purpose of this paper was to determine the applicability of the Theory of Planned Behaviour (TPB) in predicting dietary and fluid adherence among a sample of haemodialysis patients attending public sector hospitals in the Western Cape.Design and methods A sample of 62 historically disadvantaged patients undergoing haemodialysis completed a battery of psychometric instruments measuring attitudes; subjective norms; perceived behavioural control regarding dietary and fluid adherence; health literacy; perceived social support; and self-reported dietary and fluid adherence. Interdialytic weight gain (IDWG); predialytic serum potassium levels; and predialytic serum phosphate levels served as biochemical indicators of dietary and fluid adherence.Results Regression analyses indicated that the linear combination of attitudes and perceived behavioural control significantly accounted for 15.5of the variance in self-reported adherence (a medium-effect size) and 11.4of the variance in IDWG (a modest-effect size). No significant predictors were identified for predialytic serum potassium and predialytic serum phosphate levels. Interpretation and conclusions The results indicate that; while the TPB may not function in the same manner as it does in Western samples; it may have some nuanced applicability among haemodialysis patients attending public sector hospitals in the Western Cape


Assuntos
Potássio , Setor Público , Diálise Renal
6.
Parasitol Res ; 80(8): 664-71, 1994.
Artigo em Inglês | MEDLINE | ID: mdl-7886035

RESUMO

A total of 2182 serum samples from 38 patients with surgically confirmed unilocular hydatidosis, 19 clinically assessed patients, 15 patients with parasitic infections other than hydatidosis, 104 hospital outpatients, and 2006 normal Jordanians were serodiagnosed for the presence of IgG antibodies against hydatid fluid, circulating immune complexes (CIC), and/or hydatid circulating antigen (CA). Anti-hydatid IgG antibodies were detected in the sera of 77.4% of patients with hydatid disease and persist for very long periods postsurgery. As many as 54.1% of patients with hydatidosis had positive levels of CIC, and 16.1% had circulating antigen in their sera. The search for circulating antigen and CIC decreased the number of false-negative hydatid cases from seven to three, and the combined sensitivity of the assays thus increased from 77.4% to 90.3%. Using the immunoblot technique, 16- and < 14.4-kDa Echinococcus granulosus-specific bands were detected in sera from 54.1% and 61.5% of patients with hydatid disease who were tested before and after surgery, respectively. The seropositivity rate for anti-hydatid IgG antibodies was 2.4% for the general Jordanian population and 5.8% for hospital outpatients.


Assuntos
Equinococose/diagnóstico , Equinococose/epidemiologia , Adolescente , Adulto , Idoso , Anticorpos Anti-Helmínticos/sangue , Complexo Antígeno-Anticorpo/sangue , Antígenos de Helmintos/sangue , Antígenos de Helmintos/química , Criança , Equinococose/imunologia , Feminino , Humanos , Imunoglobulina G/sangue , Jordânia/epidemiologia , Masculino , Pessoa de Meia-Idade , Peso Molecular , Estudos Soroepidemiológicos , Testes Sorológicos , Fatores de Tempo
7.
Eur J Clin Pharmacol ; 45(4): 297-301, 1993.
Artigo em Inglês | MEDLINE | ID: mdl-8299659

RESUMO

The aim of this study was to investigate the use of carbamazepine in the treatment of neuralgic pain and to determine a therapeutic plasma concentration range for carbamazepine in neuralgias. The relation between plasma concentration and the response to treatment (reduction in pain) was examined by logistic regression analysis of carbamazepine and its metabolites, the epoxide, the diol, and 2-hydroxycarbamazepine. The plasma concentrations of carbamazepine, the epoxide, and the diol were significantly related to the probability of a 25% reduction in pain. Only carbamazepine was significantly related to the probability of 50% and 75% pain reduction. However, multiple regression analysis with backward elimination of the data showed a significant correlation between both carbamazepine and the epoxide with regard to the probability of 50% and 75% reductions in pain. This confirms the previous finding that the epoxide has antineuralgic properties [Tomson and Bertilsson 1984]. The therapeutic plasma concentration range for carbamazepine in neuralgias, defined as the range of concentrations that would be expected to provide a 25-75% reduction in pain in 50% of patients, was 2-7 micrograms.ml-1 (HPLC) or 5-17 micrograms.ml-1 (EMIT).


Assuntos
Carbamazepina/uso terapêutico , Neuralgia/tratamento farmacológico , Adulto , Idoso , Idoso de 80 Anos ou mais , Carbamazepina/análogos & derivados , Carbamazepina/sangue , Carbamazepina/metabolismo , Cromatografia Líquida de Alta Pressão , Técnica de Imunoensaio Enzimático de Multiplicação , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Análise de Regressão
9.
J Med Genet ; 25(12): 835-7, 1988 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-3148727

RESUMO

Visual evoked potential testing was performed on 15 Negro carriers of the gene for tyrosinase positive oculocutaneous albinism in order to detect whether they have the same visual pathway decussation anomalies as do homozygotes. No subject showed 01-02 asymmetry on monocular testing, indicating that decussation follows the normal pattern. It is concluded that visual evoked potential testing is probably not useful in the detection of Negroes heterozygous for the gene for tyrosinase positive oculocutaneous albinism.


Assuntos
Albinismo/genética , População Negra , Catecol Oxidase/genética , Potenciais Evocados Visuais , Triagem de Portadores Genéticos/métodos , Monofenol Mono-Oxigenase/genética , Adolescente , Adulto , Albinismo/enzimologia , Cor de Olho/genética , Feminino , Humanos , Pessoa de Meia-Idade , Pigmentação da Pele/genética
10.
Int J Cardiol ; 9(1): 103-5, 1985 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-3899948

RESUMO

We describe a case of Salmonella typhimurium endocarditis involving the mitral valve secondary to infection with Salmonella typhimurium. The presence of the infective agent was confirmed by blood cultures and the endocarditic lesions by cross-sectional echocardiography. Successful therapy was achieved with parenteral ampicillin and amoxicillin.


Assuntos
Amoxicilina/uso terapêutico , Ampicilina/uso terapêutico , Endocardite Bacteriana/etiologia , Infecções por Salmonella/complicações , Adulto , Amoxicilina/administração & dosagem , Ampicilina/administração & dosagem , Endocardite Bacteriana/tratamento farmacológico , Feminino , Humanos , Infusões Parenterais , Infecções por Salmonella/tratamento farmacológico , Salmonella typhimurium
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...